What does EnChannel Medical do?
EnChannel Medical is a cardiac electrophysiology innovator developing a holistic platform that integrates magnetic-impedance navigation, intracardiac echocardiography, full-chamber 5D action-potential mapping, and mid-voltage pulsed-field ablation to deliver safe and personalized treatment for atrial fibrillation.
How much did they raise?
The company raised $82.2M in its Series-B round, co-led by Dragonball Capital and Lilly Asia Ventures with participation from Lapam Capital. Previously, EnChannel completed a Series-A round of $27.8M in August 2023.
What are their plans for the money?
The proceeds from the Series-B financing will be used to accelerate product development and advance clinical registration trials both in China and internationally, paving the way for the company’s global expansion.
What have they achieved so far?
EnChannel has demonstrated progress through its successful Series-A round and the development of its investigational devices, including the DePolar Mapping System and the NanoAblate PFA System, which are progressing through clinical trials.
